Algorae Pharmaceuticals
Algorae Pharmaceuticals Limited focuses on the development and commercialization of innovative pharmaceuticals and biotechnology products. The company leverages cutting-edge research to address unmet medical needs across various therapeutic areas. Its market position is bolstered by a robust pipeline of drugs that target specific industry demands, making it a key player in pharmaceutical innovation.
Short position
Algorae Pharmaceuticals (ASX:1AI) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16,823 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. 1AI is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Algorae Pharmaceuticals (1AI) company profile
Profile, insiders and operations
Company
AI-generated research profile of Algorae Pharmaceuticals
1AI intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links